- Home
- AYI vs HALO Comparison
AYI vs HALO Comparison
Compare AYI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYI
- HALO
- Stock Information
- Founded
- AYI 2001
- HALO 1998
- Country
- AYI United States
- HALO United States
- Employees
- AYI N/A
- HALO N/A
- Industry
- AYI Building Products
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AYI Consumer Discretionary
- HALO Health Care
- Exchange
- AYI Nasdaq
- HALO Nasdaq
- Market Cap
- AYI 10.2B
- HALO 7.6B
- IPO Year
- AYI N/A
- HALO N/A
- Fundamental
- Price
- AYI $336.29
- HALO $76.90
- Analyst Decision
- AYI Buy
- HALO Buy
- Analyst Count
- AYI 5
- HALO 8
- Target Price
- AYI $352.60
- HALO $70.25
- AVG Volume (30 Days)
- AYI 226.2K
- HALO 2.0M
- Earning Date
- AYI 10-01-2025
- HALO 10-30-2025
- Dividend Yield
- AYI 0.20%
- HALO N/A
- EPS Growth
- AYI 3.17
- HALO 68.93
- EPS
- AYI 12.69
- HALO 4.37
- Revenue
- AYI $4,168,800,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- AYI $14.58
- HALO $32.57
- Revenue Next Year
- AYI $8.88
- HALO $23.25
- P/E Ratio
- AYI $26.68
- HALO $17.65
- Revenue Growth
- AYI 9.16
- HALO 34.97
- 52 Week Low
- AYI $216.81
- HALO $42.01
- 52 Week High
- AYI $345.30
- HALO $77.60
- Technical
- Relative Strength Index (RSI)
- AYI 59.31
- HALO 77.94
- Support Level
- AYI $325.85
- HALO $74.52
- Resistance Level
- AYI $345.30
- HALO $76.28
- Average True Range (ATR)
- AYI 8.33
- HALO 1.63
- MACD
- AYI -0.40
- HALO -0.06
- Stochastic Oscillator
- AYI 57.88
- HALO 88.60
About AYI Acuity Brands Inc.
Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. Acuity, Inc. designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity, Inc. has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.